TY - JOUR
T1 - The Search for the Ideal Positive Inotropic Agent
AU - Packer, M.
PY - 1993/7/15
Y1 - 1993/7/15
N2 - The belief that a depression of cardiac contractility is the fundamental defect in patients with chronic heart failure has led to the development during the past 20 years of nearly 100 new drugs with positive inotropic activity. Although all these agents exert favorable hemodynamic effects, none have produced consistent improvement in symptoms or exercise tolerance, and many have shortened the survival of patients with heart failure1,2. Questions about efficacy and safety have surfaced regardless of the drug's mechanism of action, but there has been particular concern about agents that act by inhibiting cyclic AMP phosphodiesterase (e.g., milrinone)2…
AB - The belief that a depression of cardiac contractility is the fundamental defect in patients with chronic heart failure has led to the development during the past 20 years of nearly 100 new drugs with positive inotropic activity. Although all these agents exert favorable hemodynamic effects, none have produced consistent improvement in symptoms or exercise tolerance, and many have shortened the survival of patients with heart failure1,2. Questions about efficacy and safety have surfaced regardless of the drug's mechanism of action, but there has been particular concern about agents that act by inhibiting cyclic AMP phosphodiesterase (e.g., milrinone)2…
UR - http://www.scopus.com/inward/record.url?scp=0027172674&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027172674&partnerID=8YFLogxK
U2 - 10.1056/NEJM199307153290310
DO - 10.1056/NEJM199307153290310
M3 - Editorial
C2 - 8515793
AN - SCOPUS:0027172674
SN - 0028-4793
VL - 329
SP - 201
EP - 202
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 3
ER -